Table 3 Incidence of events by combined LVEF and cT1 category

From: Cardiac and liver impairment on multiorgan MRI and risk of major adverse cardiovascular and liver events

New-onset events

N at risk

LVEF > 50% and cT1 < 800 ms

(n = 25,885)

LVEF > 50% and cT1 ≥ 800 ms

(n = 1,431)

LVEF ≤ 50% and cT1 < 800 ms

(n = 1,429)

LVEF ≤ 50% and cT1 ≥ 800 ms

(n = 96)

Hypertension

24,020

779 (3.6%)

71 (7.2%)

63 (5.8%)

4 (7.3%)

Type 2 diabetes

27,356

63 (0.3%)

22 (1.9%)

8 (0.6%)

1 (1.4%)

Liver hospitalization

28,638

234 (0.9%)

64 (4.6%)

11 (0.8%)

2 (2.1%)

Major liver events

28,797

35 (0.1%)

6 (0.4%)

4 (0.3%)

1 (1.0%)

Major CVD events

25,603

1,052 (4.5%)

71 (5.8%)

127 (12%)

10 (15%)

CVD hospitalization

28,841

1,375 (5.3%)

122 (8.5%)

197 (14%)

17 (18%)

All-cause mortality

28,841

333 (1.3%)

36 (2.5%)

37 (2.6%)

5 (5.2%)

  1. N represents the total proportion of participants in each group. N at risk shows number in whole cohort remaining after those with prevalent disease are removed from analysis. N at risk shows number in whole cohort remaining after those with prevalent disease are removed from analysis.
Back to article page